Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Public Health Genomics ; 17(1): 48-60, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24435063

RESUMEN

BACKGROUND/AIMS: This study explored the interest in genomic testing for modest changes in colorectal cancer risk and preferences for receiving genomic risk communications among individuals with intermediate disease risk due to a family history of colorectal cancer. METHODS: Surveys were conducted on 272 men and women at intermediate risk for colorectal cancer enrolled in a randomized trial comparing a remote personalized risk communication intervention (TeleCARE) aimed at promoting colonoscopy to a generic print control condition. Guided by Leventhal's Common Sense Model of Self-Regulation, we examined demographic and psychosocial factors possibly associated with interest in SNP testing. Descriptive statistics and logistic regression models were used to identify factors associated with interest in SNP testing and preferences for receiving genomic risk communications. RESULTS: Three-fourths of participants expressed interest in SNP testing for colorectal cancer risk. Testing interest did not markedly change across behavior modifier scenarios. Participants preferred to receive genomic risk communications from a variety of sources: printed materials (69.5%), oncologists (54.8%), primary-care physicians (58.4%), and the web (58.1%). Overall, persons who were unmarried (p = 0.029), younger (p = 0.003) and with greater cancer-related fear (p = 0.019) were more likely to express interest in predictive genomic testing for colorectal cancer risk. In a stratified analysis, cancer-related fear was associated with the interest in predictive genomic testing in the intervention group (p = 0.017), but not the control group. CONCLUSIONS: Individuals with intermediate familial risk for colorectal cancer are highly interested in genomic testing for modest increases in disease risk, specifically unmarried persons, younger age groups and those with greater cancer fear.


Asunto(s)
Neoplasias Colorrectales/genética , Neoplasias Colorrectales/psicología , Toma de Decisiones , Predisposición Genética a la Enfermedad/psicología , Pruebas Genéticas/estadística & datos numéricos , Polimorfismo de Nucleótido Simple/genética , Adulto , Anciano , Neoplasias Colorrectales/diagnóstico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Factores de Riesgo
2.
Prev Med ; 38(3): 276-83, 2004 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-14766109

RESUMEN

INTRODUCTION: The effectiveness of colorectal cancer screening in reducing incident colorectal cancer and the risk of death has been shown. Despite campaigns to promote the benefits of and use of colorectal cancer screening, most people are not participating in screening. In this paper, we examine factors associated with screening behavior over time, by health care provider, and by gender and report associations between screening and development of colorectal cancer after adjusting for diet and lifestyle factors. METHODS: Data from two population-based case-control studies of colorectal cancer were used to examine risk associations with nonparticipation in colorectal cancer screening. Study participants were identified for the first study between 1991 and 1994 (N = 1,346 cases and 1,544 controls) and for the second between 1997 and 2001 (N = 952 cases and 1,205 controls) and were asked to complete a detailed in-person interviewer-administered diet and lifestyle questionnaire. The control population is used to examine changes in screening behavior and associations with screening over time. RESULTS: Significantly, fewer people reported fecal occult blood test (FOBT) in 1997-2001 than in 1991-1994 (62.5% in 1991-1994 vs. 47.2% in 1997-2001); a slight nonsignificant increase in sigmoidoscopy screening was reported for these periods among controls (33.9% vs. 36.6%). In the control population, during these periods, there was a statistically significant increase in the number of people who reported having had a sigmoidoscopy for screening rather than for problems (72.6% in 1997-2001 vs. 63.8% in 1991-1994). There were differences in factors associated with screening behavior by time, by sex, and by health care provider, although having a family history of colorectal cancer, having more education, and being male was associated with more screening in all settings. After adjusting for diet and lifestyle factors, we observed that non-sigmoidoscopy screening significantly influenced risk of incident cancer (rectal OR: 2.9; 95% CI, 2.3-3.7; distal tumor OR: 1.8; 95% CI, 1.4-2.3); proximal tumor: 1.4; 95% CI, 1.1-1.8). Nonuse of FOBT also was associated significantly with tumors in the rectal (OR: 1.6; 95% CI, 1.3-1.9) and distal (OR: 1.4; 95% CI, 1.1-1.8) sites. SUMMARY: These data reinforce the importance of screening to reduce risk of colorectal cancer development. However, flexible sigmoidoscopy screening is increasing only modestly over time, and primarily in settings where a significant investment in screening has been made. FOBT screening, which is effective for rectal cancer prevention, is actually decreasing.


Asunto(s)
Neoplasias Colorrectales/diagnóstico , Conductas Relacionadas con la Salud , Tamizaje Masivo/estadística & datos numéricos , Sangre Oculta , Sigmoidoscopía/estadística & datos numéricos , Anciano , California , Femenino , Humanos , Masculino , Persona de Mediana Edad , Factores de Riesgo , Distribución por Sexo , Sigmoidoscopía/psicología , Utah
3.
Prev Med ; 33(6): 543-51, 2001 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11716649

RESUMEN

BACKGROUND: This study assessed counseling and testing needs from the perspective of adult members of a large African-American kindred with a BRCA1 mutation. METHODS: Interviews were conducted with 95 male and female kindred members to elicit information on sociodemographics, attitudes toward health care providers, breast cancer screening behaviors, and religious/spiritual beliefs, as well as to evaluate psychological distress, beliefs, knowledge, and attitudes related to genetic testing. RESULTS: Knowledge about breast and ovarian cancer genetics was limited. Adherence to screening recommendations was low among females with no personal breast or ovarian cancer history. The majority (67%) wished to discuss risk factors with a health care provider. Most participants (82%) indicated that they would have a genetic test if it were available. Significant predictors of intent to undergo testing were having at least one first-degree relative with breast and/or ovarian cancer (OR = 5.1; 95% CI = 1.2-20.9) and perceived risk of being a gene carrier > or =50% (OR = 64.3; 95% CI = 5.1-803.9) or reporting that they did not know their risk of being a gene carrier (OR = 10.9; 95% CI = 2.1-57.7). Cited barriers to testing included cost and availability. CONCLUSION: There is a high interest level in genetic testing despite limited knowledge about cancer genetics among these high-risk African Americans. Our study provides information for designing a genetic education and counseling intervention for this and similar families.


Asunto(s)
Negro o Afroamericano/psicología , Neoplasias de la Mama/genética , Genes BRCA1 , Pruebas Genéticas/psicología , Conocimientos, Actitudes y Práctica en Salud , Mutación , Neoplasias Ováricas/genética , Adulto , Anciano , Población Negra/genética , Escolaridad , Femenino , Humanos , Renta , Modelos Logísticos , Masculino , Persona de Mediana Edad
5.
Cancer ; 91(1): 57-65, 2001 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-11148560

RESUMEN

BACKGROUND: Colorectal carcinoma (CRC) may be the most frequent form of hereditary cancer. Genetic counseling and testing for heritable CRC is a promising approach for reducing the high incidence and mortality rates associated with the disease. Patients with CRC or those with at least one family member with the disease are the most likely persons to request or be offered genetic testing in the clinical or research setting. Currently, however, little is known about the behavioral, psychosocial, ethical, legal, and economic outcomes of CRC genetic counseling and testing. METHODS: Eight focus group interviews, four for CRC patients (n = 28) and four for first-degree relatives (n = 33), were conducted to obtain insights into attitudes, beliefs, and informational needs about genetic testing for hereditary CRC. RESULTS: Focus group interviews revealed a general lack of knowledge about cancer genetics and genetic testing; worry about confidentiality issues; strong concern for family members, particularly children; and a need for primary care providers to be informed about these issues. Major perceived advantages of genetic testing included improving health-related decisions, guiding physicians in making recommendations for surveillance, and informing relatives about risk potential. Disadvantages included potential discrimination, adverse psychologic effects, and financial costs associated with testing. CONCLUSIONS: As knowledge and media coverage of genetics continue to expand, it becomes increasingly important to continue efforts on behalf of, and in partnership with, those individuals most affected by genetic testing for hereditary cancer syndromes. These findings provide data needed to develop and implement informational, educational, counseling, and research-oriented programs that are sensitive to individuals' concerns and preferences.


Asunto(s)
Carcinoma/diagnóstico , Carcinoma/genética , Neoplasias Colorrectales/diagnóstico , Neoplasias Colorrectales/genética , Asesoramiento Genético , Pruebas Genéticas , Adulto , Anciano , Actitud , Confidencialidad , Toma de Decisiones , Salud de la Familia , Femenino , Grupos Focales , Conductas Relacionadas con la Salud , Humanos , Masculino , Tamizaje Masivo , Persona de Mediana Edad , Linaje , Atención Primaria de Salud , Factores de Riesgo
6.
Cancer Causes Control ; 11(4): 345-57, 2000 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10843445

RESUMEN

OBJECTIVE: The purpose of this study was to investigate the effects of alcohol consumption on breast cancer risk in black and white women. METHODS: We used data from the Carolina Breast Cancer Study, a population-based, case-control study of black and white women in North Carolina. Interviews were conducted with 890 cases and 841 controls frequency-matched on age and race. RESULTS: Overall, the prevalence of moderate to high levels of alcohol consumption was low. Compared with abstainers, the multivariate odds ratio for recent intake of one or two drinks per day was 1.4 (95% CI = 0.9-2.1) and two or more drinks a day was 1.0 (95% CI = 0.6-1.6); increasing consumption was not associated with risk (p for trend = 0.6). The associations were similar, but somewhat weaker, for average lifetime consumption. Among women who consumed 91 g/week or more of alcohol, a nonsignificant increased risk of breast cancer was observed for women reporting binge drinking (OR = 1.5; 95% CI = 0.9-2.3), but not for those who consumed less than 91 g/week reporting binge drinking (OR = 1.0; 95% CI = 0.6-1.5). Odds ratios did not differ meaningfully by race, age, menopausal status, exogenous hormone use, or body mass index. CONCLUSIONS: These data provide little evidence for an association between alcohol consumption and risk of breast cancer among either black or white women.


Asunto(s)
Consumo de Bebidas Alcohólicas/epidemiología , Negro o Afroamericano/estadística & datos numéricos , Neoplasias de la Mama/epidemiología , Población Blanca/estadística & datos numéricos , Adulto , Anciano , Consumo de Bebidas Alcohólicas/efectos adversos , Consumo de Bebidas Alcohólicas/etnología , Neoplasias de la Mama/etnología , Neoplasias de la Mama/etiología , Estudios de Casos y Controles , Femenino , Humanos , Persona de Mediana Edad , North Carolina/epidemiología , Oportunidad Relativa , Prevalencia , Factores de Riesgo , Salud de la Mujer
7.
Am J Prev Med ; 18(3): 249-52, 2000 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10722992

RESUMEN

PURPOSE: The present study examined colorectal cancer screening behaviors, risk perceptions, and willingness to receive genetic testing to determine colorectal cancer susceptibility. METHODS: We recruited 95 first-degree relatives of colorectal cancer patients, then conducted a brief telephone interview using a structured questionnaire that elicited information on sociodemographics, cancer screening behaviors, risk perceptions, and interest in genetic testing. RESULTS: Among these high-risk individuals who were aged 40 years or older, only 31% reported fecal occult blood testing within the past year and 59% reported undergoing sigmoidoscopy or colonoscopy within the past 5 years. The majority of participants believed their relative risk of colorectal cancer was increased (68%). Eighty-four percent of the participants indicated that they would have a genetic test if one were available. Participants who believed that <50% of colorectal cancers were caused by heredity were more likely to be interested in genetic testing than were participants who believed that 50% or more of colorectal cancers were caused by heredity. Referral source, sociodemographic factors, clinical factors, and perceived personal risk were not significantly associated with interest in genetic testing. CONCLUSION: Our results suggest that the demand for colorectal cancer susceptibility testing may be high among individuals with a family history of colorectal cancer. We also observed that a substantial number of first-degree relatives were not adhering to colorectal cancer screening guidelines. Accurate information on the genetic aspects of colorectal cancer and the benefits and limitations of genetic testing may help relatives of colorectal cancer patients make informed decisions about whether to undergo enhanced screening and genetic testing.


Asunto(s)
Actitud Frente a la Salud , Neoplasias Colorrectales/genética , Pruebas Genéticas/psicología , Adolescente , Adulto , Anciano , Neoplasias Colorrectales/prevención & control , Neoplasias Colorrectales/psicología , Femenino , Asesoramiento Genético , Predisposición Genética a la Enfermedad/genética , Humanos , Masculino , Tamizaje Masivo , Persona de Mediana Edad , Medición de Riesgo
8.
Cancer Pract ; 8(4): 178-86, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11898257

RESUMEN

PURPOSE: The purpose of this study was to examine risk perceptions and interest in genetic testing among African American and White patients with colorectal cancer. DESCRIPTION OF STUDY: In this cross-sectional study, 98 patients with colorectal cancer participated in a brief structured telephone interview. Information was collected on knowledge and risk perceptions regarding colorectal cancer genetics, health behaviors, knowledge about the availability of genetic testing, and interest in genetic testing for colorectal cancer susceptibility. RESULTS: Sixty-one percent of the participants were worried about their relatives' risk of colorectal cancer, and 64% were concerned about being a colorectal cancer susceptibility gene carrier. Although 81% of the participants reported that they had never heard about a genetic test for colorectal cancer susceptibility, 72% stated that they would want to take the test if it were available. Predictors of intention to have a genetic test were younger age, less advanced stage of disease, and more frequent thoughts about colorectal cancer being hereditary. CLINICAL IMPLICATIONS: These results suggest that the demand for genetic testing may be great, despite a general lack of knowledge about colorectal cancer genetics and the potential risks and limitations of testing. Education and counseling about cancer genetics and genetic testing may clarify misconceptions about hereditary colorectal cancer and help patients with colorectal cancer and their family members make informed decisions about whether to undergo testing.


Asunto(s)
Actitud Frente a la Salud/etnología , Negro o Afroamericano/psicología , Neoplasias Colorrectales/genética , Neoplasias Colorrectales/psicología , Pruebas Genéticas/psicología , Pruebas Genéticas/normas , Población Blanca/psicología , Adulto , Negro o Afroamericano/educación , Factores de Edad , Anciano , Anciano de 80 o más Años , Neoplasias Colorrectales/etnología , Estudios Transversales , Femenino , Predisposición Genética a la Enfermedad/genética , Predisposición Genética a la Enfermedad/psicología , Conocimientos, Actitudes y Práctica en Salud , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , North Carolina , Educación del Paciente como Asunto , Valor Predictivo de las Pruebas , Factores de Riesgo , Encuestas y Cuestionarios , Población Blanca/educación
9.
Nurse Pract ; 24(10): 66, 69-70, 73-4, 1999 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10546258

RESUMEN

Simple traumatic lacerations are one of the most common reasons for visits to the emergency department. Traditionally, wound repair has been performed using sutures. The use of tissue adhesives is an approved and popular alternative method of wound closure in several countries. Numerous published studies have found that, with appropriate use, repair of lacerations using tissue adhesives is faster, less painful, and more economical than suturing. Tissue adhesives result in fewer wound infections than suturing, and cosmetic outcomes have been comparable to or better than suturing. The newest product, 2-octylcyanoacrylate, received Food and Drug Administration approval in 1998 and is being marketed in the United States. The technique of wound repair with tissue adhesives is easily mastered and is a useful skill in the management of simple lacerations. This article provides a comprehensive review of the literature on the use of tissue adhesives and discusses them as an alternative to traditional methods of wound repair.


Asunto(s)
Cianoacrilatos/uso terapéutico , Adhesivos Tisulares/uso terapéutico , Heridas y Lesiones/terapia , Adulto , Niño , Humanos , Satisfacción del Paciente , Resultado del Tratamiento , Cicatrización de Heridas
10.
Prev Med ; 27(5 Pt 1): 713-9, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9808803

RESUMEN

BACKGROUND: The purpose of this study was to evaluate the effect of physician recommendation on whether to enroll in a randomized controlled chemoprevention trial for breast cancer. METHODS: We surveyed 360 women who were at increased risk for breast cancer regarding social and behavioral factors that could influence their decision to enroll or not to enroll in the Breast Cancer Prevention Trial (BCPT). Respondents completed a questionnaire following attendance at an informational session about the trial. The analysis was restricted to 175 women who discussed the possibility of their participation in the trial with their primary care physician (PCP) and who reported what their physician advised them to do regarding participation. RESULTS: Logistic regression modeling showed that among women who discussed the trial with their physician, physician recommendation was the most important factor that influenced the respondent's decision to enroll in the BCPT. Women who reported that their physician advised them to enroll in the trial were 13 times more likely to participate than were women who reported that their physicians advised them not to participate. CONCLUSIONS: The results of our study show that PCPs play an important role in influencing preventive health behavior, specifically, regarding enrollment in a randomized breast cancer chemoprevention trial. Efforts to increase recruitment to a trial should include enlisting the support of PCPs.


Asunto(s)
Anticarcinógenos/uso terapéutico , Neoplasias de la Mama/prevención & control , Consejo/estadística & datos numéricos , Toma de Decisiones , Medicina Familiar y Comunitaria/estadística & datos numéricos , Aceptación de la Atención de Salud/psicología , Selección de Paciente , Pautas de la Práctica en Medicina/estadística & datos numéricos , Ensayos Clínicos Controlados Aleatorios como Asunto , Tamoxifeno/uso terapéutico , Adulto , Anciano , Neoplasias de la Mama/etiología , Femenino , Conocimientos, Actitudes y Práctica en Salud , Humanos , Modelos Logísticos , Persona de Mediana Edad , Factores de Riesgo , Encuestas y Cuestionarios
11.
Cancer ; 80(12): 2240-9, 1997 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-9404700

RESUMEN

BACKGROUND: Sialyl-Tn (STn) represents an aberrantly glycosylated mucin epitope that is expressed in breast carcinoma and other adenocarcinomas and is an important factor in the development of novel immunotherapeutic approaches. The primary aim of the current study was to investigate the influence of STn expression on the prognoses of patients with breast carcinoma. METHODS: A cohort of 207 women diagnosed with invasive breast carcinoma who were treated with anthracycline-containing adjuvant chemotherapy and were enrolled in a randomized clinical trial were studied. Expression of STn was determined by an immunohistochemical procedure in which the B72.3 monoclonal antibody was used. Kaplan-Meier and Cox proportional regression survival analyses were used to compare low STn and high STn patients. RESULTS: Forty-eight (23%) of the 207 specimens demonstrated high STn staining (>25% cells were immunoreactive). During a median follow-up of 5 years, high STn patients had worse disease free survival than low STn patients (55% vs. 74%, respectively; P = 0.03). High STn expression was significantly associated with age (P = 0.04) but not with other conventional prognostic markers. In multivariate analysis using the Cox regression model, high STn emerged as an independent prognostic indicator for disease free survival (hazard ratio [HR], 2.02; 95% confidence interval [CI], 1.09-3.73) and for overall survival (HR, 2.16; 95% CI, 0.95-4.92). CONCLUSIONS: The results of this study suggest that STn may be a valuable marker for identifying women at high risk of developing recurrent breast carcinoma who may be candidates for trials investigating new therapies in combination with standard adjuvant therapy.


Asunto(s)
Antígenos de Carbohidratos Asociados a Tumores/biosíntesis , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Neoplasias de la Mama/patología , Carcinoma Ductal de Mama/patología , Carcinoma Lobular/patología , Adulto , Anciano , Anticuerpos Monoclonales/análisis , Anticuerpos Antineoplásicos/análisis , Biomarcadores de Tumor , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/metabolismo , Carcinoma Ductal de Mama/tratamiento farmacológico , Carcinoma Ductal de Mama/metabolismo , Carcinoma Lobular/tratamiento farmacológico , Carcinoma Lobular/metabolismo , Quimioterapia Adyuvante , Estudios de Cohortes , Ciclofosfamida/administración & dosificación , Supervivencia sin Enfermedad , Doxorrubicina/administración & dosificación , Femenino , Fluorouracilo/administración & dosificación , Humanos , Técnicas para Inmunoenzimas , Leucovorina/administración & dosificación , Metotrexato/administración & dosificación , Persona de Mediana Edad , Pronóstico , Vinblastina/administración & dosificación
12.
Oncol Nurs Forum ; 24(5): 811-20, 1997 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-9201735

RESUMEN

PURPOSE/OBJECTIVES: To describe the characteristics and activities of nurse practitioners (NP) with a focus in oncology. DESIGN: Descriptive. SAMPLE: 129 NPs employed in an oncology setting who completed on NP program and were functioning in the NP role. METHODS: Subjects completed an eight-page, self-administered questionnaire comprised of fixed-choice and open-ended questions. MAIN RESEARCH VARIABLES: Demographics, employment settings, populations served, advanced practice subroles, clinical functions, practice privileges, reimbursement issues, job descriptions, performance appraisals, job satisfaction, and facilitators/barriers to role implementation. FINDINGS: The majority of oncology NPs (ONPs) were located in the eastern United States in university-affiliated hospitals. The most common patient population served by the respondents was adults in the medical oncology outpatient setting. More than three-quarters of the respondents worked from protocols, almost two-thirds performed procedures traditionally performed by physicians, and approximately half had prescriptive authority. Few NP respondents reported that they obtained direct reimbursement for their services from third-party payors. Physicians were cited as the most facilitative of the NP role, and administrators were cited as the most frequent barrier. The vast majority of the respondents were satisfied with their roles. IMPLICATIONS FOR NURSING PRACTICE: The NP role in oncology is established and expanding. The scope of practice and more detailed characterization of the role is an area for future research. Data on the effectiveness of ONPs, particularly regarding cost-effectiveness, quality of care, and patient satisfaction, are needed to maintain their viability within the healthcare system.


Asunto(s)
Perfil Laboral , Enfermeras Practicantes/organización & administración , Enfermería Oncológica/organización & administración , Adulto , Anciano , Niño , Análisis Costo-Beneficio , Prescripciones de Medicamentos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Investigación en Evaluación de Enfermería , Satisfacción del Paciente , Autonomía Profesional , Mecanismo de Reembolso , Encuestas y Cuestionarios
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA